Infiltration therapy in the context of cartilage surgery.
TLDR
The role of a combination therapy with use of intra-articular corticosteroids is lacking in the absence of adequate study data and cannot be defined yet as discussed by the authors , however, the current scientific data do not yet justify any recommendation for its use.Abstract:
Guideline-based surgical cartilage therapy for focal cartilage damage offers highly effective possibilities to sustainably reduce patients' complaints and to prevent or at least delay the development of early osteoarthritis. In the knee joint, it has the potential to reduce almost a quarter of the arthroses requiring joint replacement caused by cartilage damage. Biologically effective injection therapies could further improve these results. Based on the currently available literature and preclinical studies, intra- and postoperative injectables may have a positive effect of platelet-rich plasma/fibrin (PRP/PRF) and hyaluronic acid (HA) on cartilage regeneration and, in the case of HA injections, also on the clinical outcome can be assumed. The role of a combination therapy with use of intra-articular corticosteroids is lacking in the absence of adequate study data and cannot be defined yet. With regard to adipose tissue-based cell therapy, the current scientific data do not yet justify any recommendation for its use. Further studies also regarding application intervals, timing and differences in different joints are required. read more
References
More filters
Journal ArticleDOI
Multilineage cells from human adipose tissue: implications for cell-based therapies.
Patricia A. Zuk,Min Zhu,Hiroshi Mizuno,Jerry I. Huang,Futrell Jw,Adam J. Katz,Prosper Benhaim,H. P. Lorenz,Marc H. Hedrick +8 more
TL;DR: The data support the hypothesis that a human lipoaspirate contains multipotent cells and may represent an alternative stem cell source to bone marrow-derived MSCs.
Journal ArticleDOI
American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee
Marc C. Hochberg,Roy D. Altman,Karine Toupin April,Maria Benkhalti,Gordon H. Guyatt,Jessie McGowan,Tanveer Towheed,Vivian Welch,George A. Wells,Peter Tugwell +9 more
TL;DR: To update the American College of Rheumatology (ACR) 2000 recommendations for hip and knee osteoarthritis (OA) and develop new recommendations for hand OA.
Journal ArticleDOI
OARSI guidelines for the non-surgical management of knee osteoarthritis
Timothy E. McAlindon,Raveendhara R. Bannuru,Matthew C. Sullivan,Nigel K Arden,Francis Berenbaum,Sita M A Bierma-Zeinstra,Gillian A. Hawker,Yves Henrotin,Yves Henrotin,David J. Hunter,Hiroshi Kawaguchi,Kent Kwoh,Stefan Lohmander,François Rannou,Ewa M. Roos,Martin Underwood +15 more
TL;DR: These evidence-based consensus recommendations provide guidance to patients and practitioners on treatments applicable to all individuals with knee OA, as well as therapies that can be considered according to individualized patient needs and preferences.
Journal ArticleDOI
EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)
K M Jordan,Nigel K Arden,M Doherty,Bernard Bannwarth,Johannes W. J. Bijlsma,Paul Dieppe,K. P. Günther,H J Hauselmann,Gabriel Herrero-Beaumont,P Kaklamanis,Stefan Lohmander,Burkhard F. Leeb,Michel Lequesne,Bernard Mazières,E. Martin-Mola,Karel Pavelka,Adrian Pendleton,Leonardo Punzi,U Serni,B Swoboda,G. Verbruggen,I Zimmerman-Gorska,Maxime Dougados +22 more
TL;DR: The updated EULAR recommendations support some of the previous propositions published in 2000 but also include modified statements and new propositions.
Journal ArticleDOI
Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules.
TL;DR: Two different types of membrane vesicles are released after stimulation of platelets with thrombin receptor agonist peptide SFLLRN or -thrombin: microvesicles of 100 nm to 1 μm, and exosomes measuring 40 to 100 nm in diameter, similar in size as the internal vesicle in MVBs and -granules.
Related Papers (5)
The use of hyaluronic acid in the treatment of osteoarthritis of knee cartilage
Beata Kwasek,Dariusz Bogdal +1 more